Literature DB >> 2513771

Pyruvate dehydrogenase complex deficiency: biochemical and immunoblot analysis of cultured skin fibroblasts.

S E Old1, D C De Vivo.   

Abstract

Cultured skin fibroblasts were obtained from 11 children with lactic acidemia and neurological disturbances. The residual activities of pyruvate dehydrogenase complex were 9 to 45% of control values in all specimens. Immunoblot analysis of mitochondrial proteins using polyclonal antibodies against the alpha and beta subunits of the first component (E1) of the pyruvate dehydrogenase complex revealed markedly decreased amounts of cross-reacting material in 4 boys who died in infancy. Two of the boys were half brothers related through a common mother. A fifth boy had an alteration of the electrophoretic mobility of the E1 alpha subunit and normal E1 beta subunit abundance. The remaining 6 patients (2 boys and 4 girls) had normal findings on Western blot assay, and all 11 patients had normal E2 and E3 patterns. These findings suggest that the E1 alpha subunit gene represents a genetically vulnerable site on the X chromosome. Decreased abundance of E1 components appears to be associated with death in infancy. A normal Western blot analysis is compatible with long-term survival despite decreased catalytic activity of the pyruvate dehydrogenase complex.

Entities:  

Mesh:

Year:  1989        PMID: 2513771     DOI: 10.1002/ana.410260610

Source DB:  PubMed          Journal:  Ann Neurol        ISSN: 0364-5134            Impact factor:   10.422


  9 in total

1.  The molecular basis of human 3-methylcrotonyl-CoA carboxylase deficiency.

Authors:  M R Baumgartner; S Almashanu; T Suormala; C Obie; R N Cole; S Packman; E R Baumgartner; D Valle
Journal:  J Clin Invest       Date:  2001-02       Impact factor: 14.808

Review 2.  The spectrum of pyruvate dehydrogenase complex deficiency: clinical, biochemical and genetic features in 371 patients.

Authors:  Kavi P Patel; Thomas W O'Brien; Sankarasubramon H Subramony; Jonathan Shuster; Peter W Stacpoole
Journal:  Mol Genet Metab       Date:  2011-10-07       Impact factor: 4.797

3.  The molecular basis of pyruvate carboxylase deficiency: mosaicism correlates with prolonged survival.

Authors:  Dong Wang; Hong Yang; Kevin C De Braganca; Jiesheng Lu; Ling Yu Shih; Paz Briones; Tim Lang; Darryl C De Vivo
Journal:  Mol Genet Metab       Date:  2008-08-03       Impact factor: 4.797

4.  The spectrum of pyruvate dehydrogenase complex deficiency: clinical, biochemical and genetic features in 371 patients.

Authors:  Kavi P Patel; Thomas W O'Brien; Sankarasubramon H Subramony; Jonathan Shuster; Peter W Stacpoole
Journal:  Mol Genet Metab       Date:  2012-07       Impact factor: 4.797

5.  A case of PDH-E1 alpha mosaicism in a male patient with severe metabolic lactic acidosis.

Authors:  A Seyda; K Chun; S Packman; B H Robinson
Journal:  J Inherit Metab Dis       Date:  2001-10       Impact factor: 4.982

Review 6.  Pyruvate dehydrogenase E1 alpha deficiency: males and females differ yet again.

Authors:  H H Dahl
Journal:  Am J Hum Genet       Date:  1995-03       Impact factor: 11.025

7.  Mutation of E1 alpha gene in a female patient with pyruvate dehydrogenase deficiency due to rapid degradation of E1 protein.

Authors:  M Ito; A H Huq; E Naito; T Saijo; E Takeda; Y Kuroda
Journal:  J Inherit Metab Dis       Date:  1992       Impact factor: 4.982

8.  Comparative biochemical studies in fibroblasts from patients with different forms of Leigh syndrome.

Authors:  M E Vazquez-Memije; S Shanske; F M Santorelli; P Kranz-Eble; E Davidson; D C DeVivo; S DiMauro
Journal:  J Inherit Metab Dis       Date:  1996       Impact factor: 4.982

9.  Intermittent peripheral weakness as the presenting feature of pyruvate dehydrogenase deficiency.

Authors:  Francois-G Debray; Marie Lambert; Michel Vanasse; Jean-Claude Decarie; Jessie Cameron; Valeriy Levandovskiy; Brian H Robinson; Grant A Mitchell
Journal:  Eur J Pediatr       Date:  2006-03-22       Impact factor: 3.183

  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.